The innate lymphocyte lineage natural killer (NK) is now the prospective of multiple clinical applications, although none has received an agreement from any regulatory agency yet. of specific NK subsets with particular activity. Finally, we propose to use specific NK cell subsets found in certain individuals that display increase activity against a specific disease, including […]